Protagonist Therapeutics (PTGX) Free Cash Flow (2018 - 2026)
Protagonist Therapeutics (PTGX) free cash flow from Mar 31, 2018 to Mar 31, 2026. The TTM Protagonist Therapeutics (PTGX) free cash flow is -$118M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Protagonist Therapeutics (PTGX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +3.82% |
| 5 Years TTM | +6.54% |
| All Time TTM | +12.43% |
Annual Free Cash Flow change of Protagonist Therapeutics (PTGX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$49M | -187.66% |
| 2025 | $56M | -69.32% |
| 2024 | $183M | -358.00% |
| 2023 | -$71M | -34.96% |
| 2022 | -$109M | -0.02% |
| 2021 | -$109M | +49.36% |
| 2020 | -$73M | +71.65% |
| 2019 | -$43M | -15.74% |
| 2018 | -$50M | -1676.25% |
| 2017 | $3.20M | N/A |
Comparison Protagonist Therapeutics (PTGX) five years free cash flow CAGR with competitors
Protagonist Therapeutics (PTGX) five years free cash flow CAGR is 6.55%.